Neurologic manifestations of the neglected tropical diseases

Aaron L. Berkowitz, Pooja Raibagkar, Bobbi S. Pritt, Farrah J. Mateen

Research output: Contribution to journalReview article

20 Citations (Scopus)

Abstract

Background The World Health Organization has identified 17 neglected tropical diseases (NTDs) that disproportionately affect the world's poorest populations. The neurologic aspects of many of these NTDs have received relatively little attention. Methods A review was performed in PubMed (MedLine) for each NTD by disease name, name of its causative organism, and neurology, neurosurgery, neurologist, brain, spinal cord, peripheral nerve, muscle, nervous system, encephalitis, meningitis, encephalopathy, stroke, neuropathy, and myopathy (1968-Sept. 2013). The Oxford Center for Evidence-based Medicine guidelines were used to determine the level of evidence of neurological involvement and treatment based on the reports identified. Results Neurologic manifestations were reported for all NTDs except yaws. Neurologic involvement was described in systematic reviews for four NTDs (Chagas disease, echinococcosis, rabies, cysticercosis) (levels 2a-3a), retrospective cohort studies for six (dengue, human African trypanosomiasis, leishmaniasis, leprosy, onchocerciasis, schistosomiasis) (levels 2b-3b), case series for one (foodborne trematodiasis) (level 4), and case reports for five (Buruli ulcer, dracunculiasis, filariasis, soil-transmitted helminthes, and trachoma). Level 1 evidence for treatment of neurologic manifestations of NTDs was found for human African trypanosomiasis, leprosy, and cysticercosis and level 2 evidence exists for treatment of neurologic involvement in Chagas disease. For the remaining NTDs, treatment of neurologic complications is described in case series and case reports only. Conclusions Neurologic manifestations of NTDs cause significant morbidity and mortality, although limited evidence exists on how best to treat these neurologic complications. Increased awareness of neurologic manifestations of the NTDs can increase their early identification and treatment, contributing to ongoing elimination and eradication campaigns.

Original languageEnglish (US)
Pages (from-to)20-32
Number of pages13
JournalJournal of the Neurological Sciences
Volume349
Issue number1-2
DOIs
StatePublished - Feb 15 2015

Fingerprint

Neglected Diseases
Neurologic Manifestations
Nervous System
African Trypanosomiasis
Cysticercosis
Chagas Disease
Leprosy
Names
Dracunculiasis
Buruli Ulcer
Yaws
Onchocerciasis
Therapeutics
Trachoma
Filariasis
Leishmaniasis
Dengue
Rabies
Evidence-Based Medicine
Schistosomiasis

Keywords

  • Central nervous system helminthiasis
  • Central nervous system parasitic infections
  • Central nervous system protozoal infections
  • Neglected diseases
  • Tropical medicine

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Medicine(all)

Cite this

Berkowitz, A. L., Raibagkar, P., Pritt, B. S., & Mateen, F. J. (2015). Neurologic manifestations of the neglected tropical diseases. Journal of the Neurological Sciences, 349(1-2), 20-32. https://doi.org/10.1016/j.jns.2015.01.001

Neurologic manifestations of the neglected tropical diseases. / Berkowitz, Aaron L.; Raibagkar, Pooja; Pritt, Bobbi S.; Mateen, Farrah J.

In: Journal of the Neurological Sciences, Vol. 349, No. 1-2, 15.02.2015, p. 20-32.

Research output: Contribution to journalReview article

Berkowitz, AL, Raibagkar, P, Pritt, BS & Mateen, FJ 2015, 'Neurologic manifestations of the neglected tropical diseases', Journal of the Neurological Sciences, vol. 349, no. 1-2, pp. 20-32. https://doi.org/10.1016/j.jns.2015.01.001
Berkowitz, Aaron L. ; Raibagkar, Pooja ; Pritt, Bobbi S. ; Mateen, Farrah J. / Neurologic manifestations of the neglected tropical diseases. In: Journal of the Neurological Sciences. 2015 ; Vol. 349, No. 1-2. pp. 20-32.
@article{0ebf389208b84dd8ac8d4037bd24ee97,
title = "Neurologic manifestations of the neglected tropical diseases",
abstract = "Background The World Health Organization has identified 17 neglected tropical diseases (NTDs) that disproportionately affect the world's poorest populations. The neurologic aspects of many of these NTDs have received relatively little attention. Methods A review was performed in PubMed (MedLine) for each NTD by disease name, name of its causative organism, and neurology, neurosurgery, neurologist, brain, spinal cord, peripheral nerve, muscle, nervous system, encephalitis, meningitis, encephalopathy, stroke, neuropathy, and myopathy (1968-Sept. 2013). The Oxford Center for Evidence-based Medicine guidelines were used to determine the level of evidence of neurological involvement and treatment based on the reports identified. Results Neurologic manifestations were reported for all NTDs except yaws. Neurologic involvement was described in systematic reviews for four NTDs (Chagas disease, echinococcosis, rabies, cysticercosis) (levels 2a-3a), retrospective cohort studies for six (dengue, human African trypanosomiasis, leishmaniasis, leprosy, onchocerciasis, schistosomiasis) (levels 2b-3b), case series for one (foodborne trematodiasis) (level 4), and case reports for five (Buruli ulcer, dracunculiasis, filariasis, soil-transmitted helminthes, and trachoma). Level 1 evidence for treatment of neurologic manifestations of NTDs was found for human African trypanosomiasis, leprosy, and cysticercosis and level 2 evidence exists for treatment of neurologic involvement in Chagas disease. For the remaining NTDs, treatment of neurologic complications is described in case series and case reports only. Conclusions Neurologic manifestations of NTDs cause significant morbidity and mortality, although limited evidence exists on how best to treat these neurologic complications. Increased awareness of neurologic manifestations of the NTDs can increase their early identification and treatment, contributing to ongoing elimination and eradication campaigns.",
keywords = "Central nervous system helminthiasis, Central nervous system parasitic infections, Central nervous system protozoal infections, Neglected diseases, Tropical medicine",
author = "Berkowitz, {Aaron L.} and Pooja Raibagkar and Pritt, {Bobbi S.} and Mateen, {Farrah J.}",
year = "2015",
month = "2",
day = "15",
doi = "10.1016/j.jns.2015.01.001",
language = "English (US)",
volume = "349",
pages = "20--32",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Neurologic manifestations of the neglected tropical diseases

AU - Berkowitz, Aaron L.

AU - Raibagkar, Pooja

AU - Pritt, Bobbi S.

AU - Mateen, Farrah J.

PY - 2015/2/15

Y1 - 2015/2/15

N2 - Background The World Health Organization has identified 17 neglected tropical diseases (NTDs) that disproportionately affect the world's poorest populations. The neurologic aspects of many of these NTDs have received relatively little attention. Methods A review was performed in PubMed (MedLine) for each NTD by disease name, name of its causative organism, and neurology, neurosurgery, neurologist, brain, spinal cord, peripheral nerve, muscle, nervous system, encephalitis, meningitis, encephalopathy, stroke, neuropathy, and myopathy (1968-Sept. 2013). The Oxford Center for Evidence-based Medicine guidelines were used to determine the level of evidence of neurological involvement and treatment based on the reports identified. Results Neurologic manifestations were reported for all NTDs except yaws. Neurologic involvement was described in systematic reviews for four NTDs (Chagas disease, echinococcosis, rabies, cysticercosis) (levels 2a-3a), retrospective cohort studies for six (dengue, human African trypanosomiasis, leishmaniasis, leprosy, onchocerciasis, schistosomiasis) (levels 2b-3b), case series for one (foodborne trematodiasis) (level 4), and case reports for five (Buruli ulcer, dracunculiasis, filariasis, soil-transmitted helminthes, and trachoma). Level 1 evidence for treatment of neurologic manifestations of NTDs was found for human African trypanosomiasis, leprosy, and cysticercosis and level 2 evidence exists for treatment of neurologic involvement in Chagas disease. For the remaining NTDs, treatment of neurologic complications is described in case series and case reports only. Conclusions Neurologic manifestations of NTDs cause significant morbidity and mortality, although limited evidence exists on how best to treat these neurologic complications. Increased awareness of neurologic manifestations of the NTDs can increase their early identification and treatment, contributing to ongoing elimination and eradication campaigns.

AB - Background The World Health Organization has identified 17 neglected tropical diseases (NTDs) that disproportionately affect the world's poorest populations. The neurologic aspects of many of these NTDs have received relatively little attention. Methods A review was performed in PubMed (MedLine) for each NTD by disease name, name of its causative organism, and neurology, neurosurgery, neurologist, brain, spinal cord, peripheral nerve, muscle, nervous system, encephalitis, meningitis, encephalopathy, stroke, neuropathy, and myopathy (1968-Sept. 2013). The Oxford Center for Evidence-based Medicine guidelines were used to determine the level of evidence of neurological involvement and treatment based on the reports identified. Results Neurologic manifestations were reported for all NTDs except yaws. Neurologic involvement was described in systematic reviews for four NTDs (Chagas disease, echinococcosis, rabies, cysticercosis) (levels 2a-3a), retrospective cohort studies for six (dengue, human African trypanosomiasis, leishmaniasis, leprosy, onchocerciasis, schistosomiasis) (levels 2b-3b), case series for one (foodborne trematodiasis) (level 4), and case reports for five (Buruli ulcer, dracunculiasis, filariasis, soil-transmitted helminthes, and trachoma). Level 1 evidence for treatment of neurologic manifestations of NTDs was found for human African trypanosomiasis, leprosy, and cysticercosis and level 2 evidence exists for treatment of neurologic involvement in Chagas disease. For the remaining NTDs, treatment of neurologic complications is described in case series and case reports only. Conclusions Neurologic manifestations of NTDs cause significant morbidity and mortality, although limited evidence exists on how best to treat these neurologic complications. Increased awareness of neurologic manifestations of the NTDs can increase their early identification and treatment, contributing to ongoing elimination and eradication campaigns.

KW - Central nervous system helminthiasis

KW - Central nervous system parasitic infections

KW - Central nervous system protozoal infections

KW - Neglected diseases

KW - Tropical medicine

UR - http://www.scopus.com/inward/record.url?scp=84923944450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923944450&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2015.01.001

DO - 10.1016/j.jns.2015.01.001

M3 - Review article

C2 - 25623803

AN - SCOPUS:84923944450

VL - 349

SP - 20

EP - 32

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -